Overview of comments received on Draft Qualification Opinion of the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients(iBox 评分系统作为肾脏移植患者中新型免疫抑制药物临床试验次要疗效终点的资格审查意见草案综述)